Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INO-4800 COVID-19 booster study in healthy adults in Ghana
PACTR202206666476182Phase 1Unknown
- Sponsor
- Inovio Pharmaceuticals, Inc.
- Start
- Aug 2022
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of INO-4800 and INO-9112 in coronavirus disease 2019 (COVID-19), sponsored by Inovio Pharmaceuticals, Inc. Status: unknown.
02
Drugs
INO-4800INO-9112
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202206666476182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202206666476182.